These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 1610484
1. Nitrotriazoles bearing sulfur-substituted side chains: preparation and characterization as hypoxic cell radiosensitizers. Sugita T, Masuoka M, Nishikawa Y, Nishimoto S, Zhou L, Sasai K, Kagiya T. Anticancer Drug Des; 1992 Jun; 7(3):277-84. PubMed ID: 1610484 [Abstract] [Full Text] [Related]
2. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain. Kagiya VT, Sugita T, Nishimoto S, Masuoka M, Zhou L, Abe M, Shibamoto Y, Sasai K. Int J Radiat Oncol Biol Phys; 1992 Jun; 22(3):597-600. PubMed ID: 1735698 [Abstract] [Full Text] [Related]
3. Radiosensitizing hypoxic cells with new 3-nitro-1,2,4-triazole derivatives in vitro and in vivo. Nagao Y, Sano S, Ochiai M, Fuji K, Nishimoto S, Kagiya T, Murayama C, Mori T, Shibamoto Y, Sasai K. Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1951-3. PubMed ID: 2805177 [Abstract] [Full Text] [Related]
4. Radiosensitization in vitro and in vivo by 3-nitrotriazoles. Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M. Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928 [Abstract] [Full Text] [Related]
5. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics. Sasai K, Iwai H, Yoshizawa T, Nishimoto S, Shibamoto Y, Oya N, Shibata T, Abe M. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):579-82. PubMed ID: 8005818 [Abstract] [Full Text] [Related]
6. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents. Jenkins TC, Stratford IJ, Stephens MA. Anticancer Drug Des; 1989 Aug 15; 4(2):145-60. PubMed ID: 2803463 [Abstract] [Full Text] [Related]
7. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro. Zhou L, Nishimoto S. Int J Radiat Biol; 1995 Mar 15; 67(3):335-46. PubMed ID: 7897282 [Abstract] [Full Text] [Related]
13. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer. Kasai S, Nagasawa H, Kuwasaka H, Oshodani T, Nishioka A, Ogawa Y, Yoshida S, Inayama S, Inomata T, Hori H. Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):799-802. PubMed ID: 9845099 [Abstract] [Full Text] [Related]
15. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K. Anticancer Res; 2006 Nov 01; 26(2A):1261-70. PubMed ID: 16619533 [Abstract] [Full Text] [Related]
16. [Radiosensitizing properties of an analog of azathioprine]. Van Caneghem P, Jamoulle JC, Lapière CL. Ann Pharm Fr; 1985 Nov 01; 43(4):365-71. PubMed ID: 3837623 [No Abstract] [Full Text] [Related]
17. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity. Lee HH, Wilson WR, Denny WA. Anticancer Drug Des; 1999 Dec 01; 14(6):487-97. PubMed ID: 10834270 [Abstract] [Full Text] [Related]
18. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline]. Skov KA, Adomat H, Doedee M, Farrell N. Anticancer Drug Des; 1994 Apr 01; 9(2):103-17. PubMed ID: 8166927 [Abstract] [Full Text] [Related]
20. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA. J Med Chem; 1996 Jun 21; 39(13):2518-28. PubMed ID: 8691449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]